CING
CING
NASDAQ · Pharmaceuticals

Cingulate Inc

$7.38
-0.13 (-1.73%)
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 8 89%
Hold 1 11%
Sell 0 0%
Price Target
Analyst Price Target +94.9% upside
Low Target $9.95
Average Target $14.38
High Target $17.66
Current Price $7.38
Current
$7.38
Target
$14.38
$9.95 $14.38 avg $17.66
Scenario Analysis
Bear Case
$9.95
34.8%
Low target
Base Case
$14.38
+94.9%
Avg target
Bull Case
$17.66
+139.3%
High target
Risk/Reward
4.0x
Highly favorable
Price in Context
52-Week High
$11.89
-37.9% from high
52-Week Low
$3.20
+130.6% from low
Target vs 52W High
$14.38
+20.9% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
Buy 18 67% $122.82 +809.8%